We are live on ! Find out more
KURA icon

Kura Oncology
KURA

141 hedge funds and large institutions have $885M invested in Kura Oncology in 2023 Q1 according to their latest regulatory filings, with 15 funds opening new positions, 49 increasing their positions, 41 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

67% more funds holding in top 10

Funds holding in top 10: 3 → 5 (+2)

20% more repeat investments, than reductions

Existing positions increased: 49 | Existing positions reduced: 41

3.11% more ownership

Funds ownership: 102.75% → 105.86% (+3.1%)

4% more capital invested

Capital invested by funds: $849M → $885M (+$36.1M)

1% less funds holding

Funds holding: 142 → 141 (-1)

6% less first-time investments, than exits

New positions opened: 15 | Existing positions closed: 16

21% less call options, than puts

Call options by funds: $535K | Put options by funds: $679K

Holders
141
Holders Change
-1
Holders Change %
-0.7%
% of All Funds
2.25%
Holding in Top 10
5
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+66.67%
% of All Funds
0.08%
New
15
Increased
49
Reduced
41
Closed
16
Calls
$535K
Puts
$679K
Net Calls
-$144K
Net Calls Change
-$935K

Top Buyers

Rank Fund Capital Flow
1
BI
BVF Inc
California
+$36.6M
2
Citadel Advisors
Citadel Advisors
Florida
+$15.1M
3
WP
Woodline Partners
California
+$6.11M
4
Bank of America
Bank of America
North Carolina
+$3.08M
5
BlackRock
BlackRock
New York
+$2.58M

Top Sellers

Rank Fund Capital Flow
1
Victory Capital Management
Victory Capital Management
Texas
-$18.9M
2
Balyasny Asset Management
Balyasny Asset Management
Illinois
-$14.4M
3
State Street
State Street
Massachusetts
-$7.53M
4
Axa
Axa
France
-$3.68M
5
T. Rowe Price Investment Management
T. Rowe Price Investment Management
Maryland
-$2.73M
Name Holding Trade Value Shares
Change 		Change in
Stake
BI
1
BVF Inc
California
$82.3M +$36.6M +2,930,000 +77%
EC
2
EcoR1 Capital
California
$81.2M – – –
SCM
3
Suvretta Capital Management
New York
$80.4M +$2.45M +196,520 +3%
BlackRock
4
BlackRock
New York
$65.7M +$2.58M +206,471 +4%
State Street
5
State Street
Massachusetts
$47M -$7.53M -603,749 -14%
Vanguard Group
6
Vanguard Group
Pennsylvania
$42.6M +$974K +78,051 +2%
ACA
7
Avoro Capital Advisors
New York
$38M – – –
T. Rowe Price Investment Management
8
T. Rowe Price Investment Management
Maryland
$30M -$2.73M -218,533 -8%
Holocene Advisors
9
Holocene Advisors
New York
$29.8M -$1.26M -101,142 -4%
DM
10
Deerfield Management
New York
$29.1M – – –
Citadel Advisors
11
Citadel Advisors
Florida
$23.7M +$15.1M +1,211,847 +167%
FCMI
12
Foresite Capital Management IV
California
$22.6M – – –
Dimensional Fund Advisors
13
Dimensional Fund Advisors
Texas
$22.4M +$1.67M +133,912 +8%
AG
14
Artal Group
Luxembourg
$21M +$225K +18,056 +1%
TCM
15
TCG Crossover Management
California
$17.4M – – –
Geode Capital Management
16
Geode Capital Management
Massachusetts
$15.7M +$713K +57,110 +5%
AC
17
Armistice Capital
New York
$15.1M +$2.05M +164,000 +15%
CC
18
Commodore Capital
New York
$14.7M +$1.32M +105,551 +10%
Franklin Resources
19
Franklin Resources
California
$14.6M +$1.58M +126,416 +12%
Assenagon Asset Management
20
Assenagon Asset Management
Luxembourg
$14.1M – – –
Balyasny Asset Management
21
Balyasny Asset Management
Illinois
$14M -$14.4M -1,152,963 -50%
Goldman Sachs
22
Goldman Sachs
New York
$13.3M -$757K -60,691 -5%
CS
23
Candriam SCA
Luxembourg
$9.17M – – –
N
24
Nuveen
North Carolina
$8.07M -$444K -35,560 -5%
Northern Trust
25
Northern Trust
Illinois
$7.74M -$1.6M -128,032 -17%
1
2 3 4 5

KURA Hedge Fund Activity: Q1 2023 in Review

141 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in Kura Oncology (KURA) for Q1 2023, worth a combined $885M — up 4.2% from $849M a quarter earlier.

Sellers outnumbered buyers: 16 funds closed out of KURA and 15 opened new positions — a net loss of 1 holder — while 41 trimmed existing stakes and 49 added.

The largest buyer was BVF Inc, adding an estimated $36.6M. The largest seller was Victory Capital Management, exiting entirely with an estimated $18.9M sold.

  • 141 institutional investors held Kura Oncology (KURA) as of Q1 2023, down from 142 in Q4 2022.
  • Funds reported $885M of Kura Oncology stock for Q1 2023, up 4.2% quarter-over-quarter.
  • 15 funds opened new Kura Oncology positions in Q1 2023 and 16 closed out, a net change of -1 holder.
  • The largest Kura Oncology buyer in Q1 2023 was BVF Inc, an estimated $36.6M added.
  • The largest Kura Oncology seller in Q1 2023 was Victory Capital Management, an estimated $18.9M sold.

Based on aggregated 13F filings for Q1 2023.